TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT07083960: OM336 in Autoimmune Cytopenias

Sponsor: Lakefront Biotherapeutics West LLC · Phase: PHASE1 · Area: IMMUNOLOGY · Target Enrollment: 32 pts

Competing Trials Overlap

6 Active Trials

Excess Burn Exposure

$774,180

Rescue Site Savings

+$516,120

Unlock Full NCT07083960 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07083960 Rescue Dossier →